cGxP.wire https://validator.w3.org/feed/docs/rss2.html Heru Launches PretestPro for Prime Diagnostic Headset GE HealthCare Advances StarGuide GX for Theranostics Definium Therapeutics Gains FDA Breakthrough Therapy Designation for DT120 in MDD Verastem Oncology Advances VS-7375 Across KRAS G12D Cancers Faeth Therapeutics Highlights PIKTOR Strategy Ahead of Phase 2 Data Kelun-Biotech’s WIN378 Advances to Phase 3 in Asthma Dyne Therapeutics Advances Z-Basivarsen Toward Phase 3 in DM1 Pulmovant Advances Mosliciguat Into Phase 3 After Positive PHocus Data Anitoa Adds Secure Cloud Connectivity to Portable qPCR Pharvaris Reports Positive Phase 3 CHAPTER-3 Data for Deucrictibant XR Vor Bio Completes Phase 3 UPSTREAM MG Enrollment and Expands Telitacicept Into Ocular MG Harbour BioMed’s WIN378 Shows Positive Phase 2 Asthma Data BrainChild Bio Initiates Pivotal Phase 2 Trial of BCB-276 for DIPG Alebund’s AP308 Gets FDA IND Clearance for IgA Nephropathy Sernova and Seraxis Merge to Create BetaNova Biotherapeutics Abbott Wins FDA Approval for TactiFlex Duo AFib Catheter Johnson & Johnson Highlights New Neuropsychiatry Data Monte Rosa Advances MRT-6160 Into Phase 2 for Sjögren’s Disease Alpha-9 Oncology Starts Phase 1 GRPR Radiotherapeutic Trial Nkarta to Present Initial NKX019 Autoimmune Data at ACR 2026 Artiva Biotherapeutics Advances AlloNK Toward Phase 3 in RA Medicus Pharma Advances Precision Oncology Strategy With CD228V Kenvue’s TYLENOL With Naproxen Shows Lasting Pain Relief Brainomix Reports Positive AI Imaging Data in IPF Trial INBRX-106 Doubles Response Rate in Phase 2 HNSCC PeproMene Reports Durable Responses With BAFF-R CAR T BMS Reports Positive Phase 2 CAR T Cell Trial Results Belite Bio Files Japan NDA for Tinlarebant in Stargardt Disease Caris Life Sciences Promotes Caris Detect for Cancer Ascletis Begins U.S. Phase 1 Study of ASC36 Insightec Reaches 10,000 EMEA Patients With MRgFUS Epicyt Pharma Advances BAFA Toward Phase 2b Development Infex Therapeutics Advances RESP-X Toward Next-Stage Development Greywolf Therapeutics Advances GRWD0715 Into axSpA Trial Upstream Bio Advances Verekitug Toward Phase 3 in Asthma Novartis Reports Phase III HARBOR Setback for Del-desiran Prodia the CRO Receives Frost & Sullivan 2026 Customer Value Recognition DelveInsight: CABP Market Set for Growth Through 2036 Nyxoah Begins U.S. BREATHE Study With First Genio Implant Aptar Pharma, Aceso Advance Inhaled ASO Therapy Guardant Health Wins FDA Approval for Breast Cancer CDx Novo Nordisk Reports Positive STEP Young Phase 3 Data Resonant Expands Biorepository Network With Creapharm Deal CelluPro Gains EXCiPACT GMP Certification in China FDA Acts to Protect Access to Newborn Nutrition Products Vertex Completes Crinetics Acquisition in $10 Billion Deal Fosun Pharma Launches HK$1 Billion H-Share Repurchase FDA Grants Accelerated Approval to Etcamah for Breast Cancer SynAct Pharma Advances Resomelagon Toward Phase 3 in RA Ascletis Joins Hong Kong Stock Connect Programs